Stock AXDX ACCELERATE DIAGNOSTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Accelerate Diagnostics, Inc.

Equities

AXDX

US00430H2013

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
1.25 USD +6.84% Intraday chart for Accelerate Diagnostics, Inc. -14.97% -68.11%
May. 20 Accelerate Diagnostics, Inc. announced that it has received $4.7 million in funding from Jack W. Schuler Living Trust CI
May. 08 Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q1 Revenue $2.9M, vs. Street Est of $3M
MT
Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Accelerate Diagnostics Announces Collaboration for the Use of the Arc System in Combination With Bruker´s MALDI Biotyper
CI
Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q3 Revenue $3.3M
MT
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q2 Revenue $2.9M
MT
Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q1 Revenue $2.8M
MT
Accelerate Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Accelerate Diagnostics Files Application With US FDA to Update PhenoTest BC Kit
MT
Accelerate Diagnostics Submits 510(K) Application to FDA for Gram-Negative Menu Expansion and Breakpoint Updates for the Accelerate Phenotest(R) BC Kit
CI
Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q3 Revenue $3M
MT
Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Reports Q2 Revenue $3.9M
MT
Accelerate Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Becton, Dickinson to Collaborate With Accelerate Diagnostics on Rapid Antimicrobial Identification Offerings
MT
BD, Accelerate Diagnostics Announces Global Commercial Collaboration
CI
Accelerate Diagnostics' Accelerate Arc Module, BC Kit Get CE Marking
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AXDX Stock
  4. News Accelerate Diagnostics, Inc.
  5. Highlights